Skip to main content
Clinical Trials/IRCT20141209020258N129
IRCT20141209020258N129
Recruiting
Phase 2

Effect of combination of Propofol-Remifentanil versus Ketofel in duration of seizure and hemodynamic signs of psychotics patient in electroconvulsive therapy

Arak University of Medical Sciences0 sites105 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
psychotics patient.
Sponsor
Arak University of Medical Sciences
Enrollment
105
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 to 50 years
  • Patients with a diagnosis of major schizophrenia depression of catatonia or bipolar disorder
  • ASA class I and II

Exclusion Criteria

  • Sensitivity to medications used
  • Drug history
  • History of cardiovascular disease
  • Patients in need of treatment for hemodynamic instability following seizures, who had less than 25 second tonic or clonic seizures, or had more than 60% energy to induce seizures

Outcomes

Primary Outcomes

Not specified

Similar Trials